ahlam1399
07-28-2016, 08:54 AM
BRIEF-Fda approves Lixisenatide as Adlyxintm for treatment of adults with type 2 diabetes in U.S.
* Fda approves lixisenatide as adlyxintm for treatment of
adults with type 2 diabetes in u.s.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=6sQ22u4gw9U:kiM1toEdOJw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=6sQ22u4gw9U:kiM1toEdOJw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/6sQ22u4gw9U
* Fda approves lixisenatide as adlyxintm for treatment of
adults with type 2 diabetes in u.s.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=6sQ22u4gw9U:kiM1toEdOJw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=6sQ22u4gw9U:kiM1toEdOJw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=6sQ22u4gw9U:kiM1toEdOJw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/6sQ22u4gw9U